Recent Quotes (30 days)

You have no recent quotes
chg | %

Response Biomedical Corp. (ADR)  

(Public, OTCBB:RPBIF)   Watch this stock  
Find more results for RPBIF
0.842
0.000 (0.00%)
Nov 25 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.71 - 1.80
Open     -
Vol / Avg. 0.00/668.00
Mkt cap 6.87M
P/E 7.11
Div/yield     -
EPS 0.12
Shares 7.95M
Beta 3.80
Inst. own     -
Nov 10, 2014
Q3 2014 Response Biomedical Corp Earnings Call
Nov 10, 2014
Q3 2014 Response Biomedical Corp Earnings Release
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -50.84% -52.02%
Operating margin -104.09% -27.79%
EBITD margin - -19.18%
Return on average assets -34.42% -42.01%
Return on average equity - -
Employees 65 -
CDP Score - -

Address

1781 - 75TH AVENUE W.
VANCOUVER, BC V6P6P2
Canada
+1-604-4566010 (Phone)
+1-604-4566066 (Fax)

Website links

Description

Response Biomedical Corp. (Response) is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets. The Company develops, manufactures and sells its RAMP system for the global medical point of care market, including cardiovascular testing, infectious disease testing market and the on-site environmental testing market, including biodefense and vector environmental testing. In the United States, its RAMP 200 Reader is limited to central-lab use with the cardiovascular tests. POC, on-site diagnostic tests (or assays), are non-laboratory based tests performed using portable hand-held devices, compact desktop analyzers, single-use test cartridges and/or dipsticks RAMP represents a paradigm in diagnostics that provides information in minutes.

Officers and directors

William J. Adams Chief Financial Officer, Corporate Secretary
Age: 51
Barbara Kinnaird Ph.D. Chief Operating Officer
Age: 46
Zheng Wang General Manager, Asia Pacific
Lewis J. Shuster Chairman of the Board
Anthony F. Holler M.D. Interim Chief Executive Officer, Director
Age: 61
Peter A. Thompson M.D. Director
Jonathan Wang Ph.D. Director
Age: 45
Joseph D. Keegan Ph.D. Independent Director
Clinton H. Severson Independent Director
Age: 66
David G. Wang MD, PhD Independent Director
Age: 51